Urology · Tallahassee, FL
NPI
1679594402
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2000 Centre Pointe Blvd
Tallahassee, FL, 32308
Phone (850) 309-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$257K
17,465 services
Medicare patients, 2024
930
Average age 75
Drug cost, 2024
$736K
4,397 prescriptions
Company payments, 2025
$1,367
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David E Burday was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 4,000 times for 39 patients. In total David E Burday billed 17,465 services in 86 codes, and Medicare paid $257K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-08.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 4,000 | 39 | $0.10 | $394 |
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,050 | 12 | $1.98 | $4,065 |
| 81003 Clinical Chemistry | Office | 977 | 671 | $2.19 | $2,138 |
| 99214 Office E&M - Established | Office | 782 | 551 | $97.44 | $76K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 566 | 434 | $12.82 | $7,257 |
| 99213 Office E&M - Established | Office | 287 | 254 | $70.21 | $20K |
| 36415 Venipuncture Blood Collection | Office | 202 | 161 | $7.13 | $1,440 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 196 | 47 | $51.29 | $10K |
| 51798 Ultrasound - Nonspecific | Office | 179 | 167 | $8.30 | $1,485 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 146 | 21 | $140.58 | $21K |
| 99204 Office E&M - New | Office | 146 | 146 | $128.09 | $19K |
| 52000 Cystourethroscopy | Facility | 93 | 80 | $59.62 | $5,545 |
| 74018 Standard X-ray | Office | 86 | 69 | $23.77 | $2,044 |
| 51702 Other Organ Systems | Office | 61 | 26 | $49.92 | $3,045 |
| 96372 Injection Administration | Office | 52 | 43 | $11.37 | $591 |
By year: 2022 $231K for 17,759 services; 2023 $216K for 14,201 services; 2024 $257K for 17,465 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 977 | 671 | $2.19 | $2,138 |
| 36415 Venipuncture Blood Collection | 202 | 161 | $7.13 | $1,440 |
| 81002 Clinical Chemistry | 38 | 37 | $3.41 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug David E Burday prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,220 prescriptions and refills. In total David E Burday wrote 4,397 Medicare prescriptions that cost $736K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,220 | 3,326 | 387 | $20K |
| Finasteride Generic | 651 | 1,850 | 189 | $9,718 |
| Myrbetriq Mirabegron | 634 | 1,289 | 158 | $558K |
| Dutasteride Generic | 316 | 871 | 105 | $8,794 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 225 | 574 | 68 | $4,626 |
| Ciprofloxacin Hcl Generic | 139 | 139 | 109 | $395 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 125 | 227 | 53 | $4,833 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 118 | 283 | 39 | $3,162 |
| Estradiol Generic | 84 | 195 | 42 | $5,183 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 84 | 85 | 64 | $415 |
| Gemtesa Vibegron | 66 | 146 | 26 | $68K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 61 | 61 | 55 | $214 |
| Testosterone Generic | 57 | 59 | 12 | $5,917 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 53 | 55 | 42 | $1,105 |
| Trimethoprim Generic | 46 | 85 | 12 | $2,509 |
Brand drugs: - claims; generic drugs: 3,613 claims; opioid claims: 87.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David E Burday $1,367 ($1,367 in general payments such as food, travel and fees) from 21 companies. The largest payer was Boston Scientific Corporation with $243.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 7 | $243 |
| Ferring Pharmaceuticals Inc. | 6 | $213 |
| Telix Pharmaceuticals TLX | 1 | $115 |
| Pfizer Inc. PFE | 5 | $110 |
| Dendreon Pharmaceuticals LLC | 3 | $90.54 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $81.76 |
| Abbvie Inc. ABBV | 3 | $66.1 |
| Janssen Biotech, Inc. JNJ | 3 | $59.49 |
| Tolmar, Inc. | 2 | $52.83 |
| Astellas Pharma US Inc 4503.T | 2 | $44.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.